Disc Medicine Stock Gross Profit
| IRON Stock | 64.22 0.77 1.21% |
Disc Medicine fundamentals help investors to digest information that contributes to Disc Medicine's financial success or failures. It also enables traders to predict the movement of Disc Stock. The fundamental analysis module provides a way to measure Disc Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Disc Medicine stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | -100 K | -105 K |
Disc | Gross Profit |
Disc Medicine Company Gross Profit Analysis
Disc Medicine's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Disc Medicine Gross Profit | (105K) |
Most of Disc Medicine's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Disc Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Disc Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Disc Medicine is extremely important. It helps to project a fair market value of Disc Stock properly, considering its historical fundamentals such as Gross Profit. Since Disc Medicine's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Disc Medicine's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Disc Medicine's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
Disc Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Disc Medicine's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Disc Medicine could also be used in its relative valuation, which is a method of valuing Disc Medicine by comparing valuation metrics of similar companies.Disc Medicine is currently under evaluation in gross profit category among its peers.
Disc Medicine ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Disc Medicine's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Disc Medicine's managers, analysts, and investors.Environmental | Governance | Social |
Disc Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.18 | ||||
| Current Valuation | 1.4 B | ||||
| Shares Outstanding | 29.76 M | ||||
| Shares Owned By Insiders | 12.47 % | ||||
| Shares Owned By Institutions | 97.73 % | ||||
| Number Of Shares Shorted | 1.64 M | ||||
| Price To Book | 4.03 X | ||||
| EBITDA | (91.03 M) | ||||
| Net Income | (76.43 M) | ||||
| Total Debt | 2.1 M | ||||
| Book Value Per Share | 15.73 X | ||||
| Cash Flow From Operations | (73.46 M) | ||||
| Short Ratio | 3.92 X | ||||
| Earnings Per Share | (3.95) X | ||||
| Target Price | 92.75 | ||||
| Number Of Employees | 82 | ||||
| Market Capitalization | 1.92 B | ||||
| Total Asset | 368 M | ||||
| Retained Earnings | (188.65 M) | ||||
| Working Capital | 344.22 M | ||||
| Net Asset | 368 M |
About Disc Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Disc Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Disc Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Disc Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Disc Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Disc Stock
| 0.68 | ME | 23Andme Holding | PairCorr |
| 0.66 | VALN | Valneva SE ADR | PairCorr |
| 0.63 | DOMH | Dominari Holdings | PairCorr |
| 0.6 | EQ | Equillium | PairCorr |
| 0.6 | DRRX | Durect | PairCorr |
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Disc Medicine Piotroski F Score and Disc Medicine Altman Z Score analysis. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Return On Assets (0.18) | Return On Equity (0.25) |
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.